Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

VEGF

  • You have access
    Phosphofructokinase 1 Platelet Isoform Enhances VEGF Expression in Part Through HIF-1α Up-regulation in Breast Cancer
    JONG-HO LEE
    Anticancer Research January 2023, 43 (1) 75-84; DOI: https://doi.org/10.21873/anticanres.16136
  • You have access
    Therapeutic Response Evaluation in Advanced Melanoma Patients Incorporating Plasma cfDNA, LDH, VEGF, PD-L1, and IFN-γ Measurements
    MICHAEL I. ITA, JIANG H. WANG, CYNTHIA C. HEFFRON, DEREK G. POWER, YVONNE NOLAN, ANDRÉ TOULOUSE, CHRIS C.H. LIM, NOEL FANNING and HENRY P. REDMOND
    Anticancer Research February 2022, 42 (2) 801-810; DOI: https://doi.org/10.21873/anticanres.15538
  • You have access
    Effects of Hypoxia on Proliferation and Apoptosis of Osteosarcoma Cells
    SHANG-YOU YANG, ELKA GARCIA, WILL XIA and ANYU WANG
    Anticancer Research October 2021, 41 (10) 4781-4787; DOI: https://doi.org/10.21873/anticanres.15293
  • You have access
    Clinical Trial of a Cancer Vaccine Targeting VEGF and KIF20A in Advanced Biliary Tract Cancer
    MUTSUNORI MURAHASHI, TOSHIHISA TSURUTA, KAZUNARI YAMADA, YASUKI HIJIKATA, HISANOBU OGATA, JUNJI KISHIMOTO, SACHIKO YOSHIMURA, TETSURO HIKICHI, YOICHI NAKANISHI and KENZABURO TANI
    Anticancer Research March 2021, 41 (3) 1485-1496; DOI: https://doi.org/10.21873/anticanres.14907
  • You have access
    Antiangiogenic Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: Focusing on Regorafenib
    MARIOS PAPADIMITRIOU and CHRISTOS A. PAPADIMITRIOU
    Anticancer Research February 2021, 41 (2) 567-582; DOI: https://doi.org/10.21873/anticanres.14809
  • You have access
    Antitumor Activity of Rivoceranib Against Canine Mammary Gland Tumor Cell Lines
    JEONG-HA LEE, QIANG LI, JU-HYUN AN, HYUNG-KYU CHAE, JIN-WOO CHOI, BUM-JIN KIM, WOO-JIN SONG and HWA-YOUNG YOUN
    Anticancer Research October 2019, 39 (10) 5483-5494; DOI: https://doi.org/10.21873/anticanres.13741
  • You have access
    State of the Art for Metastatic Pancreatic Cancer Treatment: Where Are We Now?
    RITA BALSANO, CHIARA TOMMASI and INGRID GARAJOVA
    Anticancer Research July 2019, 39 (7) 3405-3412; DOI: https://doi.org/10.21873/anticanres.13484
  • You have access
    RAW 264.7 Macrophage Polarization by Pancreatic Cancer Cells – A Model for Studying Tumour-promoting Macrophages
    AYDAR KHABIPOV, ANDRE KÄDING, KIM ROUVEN LIEDTKE, ERIC FREUND, LARS-IVO PARTECKE and SANDER BEKESCHUS
    Anticancer Research June 2019, 39 (6) 2871-2882; DOI: https://doi.org/10.21873/anticanres.13416
  • You have access
    OPG, OPN, EGF and VEGF Levels at Individual Breslow Score Stages in Malignant Melanoma
    INKA TRESKOVA, ONDREJ TOPOLCAN, JINDRA WINDRICHOVA, VACLAV SIMANEK, DAVID SLOUKA, VLADISLAV TRESKA and RADEK KUCERA
    Anticancer Research August 2018, 38 (8) 4907-4911; DOI: https://doi.org/10.21873/anticanres.12806
  • You have access
    Expression and Prognostic Impact of VEGF, CD31 and αSMA in Resected Primary Lung Cancers
    KATSUO USUDA, SYUN IWAI, AIKA FUNASAKI, ATSUSHI SEKIMURA, NOZOMU MOTONO, YOSHIMITI UEDA, MIYAKO SHIMAZAKI and HIDETAKA URAMOTO
    Anticancer Research July 2018, 38 (7) 4057-4063; DOI: https://doi.org/10.21873/anticanres.12695

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire